GlassScriptPhysician profile
Krishnan Perumbala
NPI 1548848427
$2,494.71
in general payments reported to CMS, 2019-2025
10 companies · $478 in 2025
The $478 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,211 · 2023: $541 · 2024: $265 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,283.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $1,273.45 | 2022-2024 | |
| Novus Surgical Consultants | $278.12 | 2024-2025 | |
| Stryker Corporation | $201.21 | 2024-2025 | Ortholoc 3di, Flexband, Ortholoc 3di Crosscheck |
| Integra Lifesciences Corporation | $150.80 | 2023 | Tenoglide |
| Kerecis Limited | $149.41 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Heron Therapeutics, INC. | $122.11 | 2023 | Zynrelef |
| Inari Medical, INC. | $118.38 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Extremity Medical | $109.38 | 2024 | |
| Paragon 28, INC. | $76.60 | 2025 | Mtp |
| Solventum Corporation | $15.25 | 2025 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishnan Perumbala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.